(redirected from inactivator)
Also found in: Dictionary, Thesaurus, Medical.
See: disable
Mentioned in ?
References in periodicals archive ?
Presurgical treatment with vitamin E, another free-radical inactivator, appeared to limit heart damage from coronary artery bypass surgery (138: 333).
EDTA, a metalloprotease inactivator, achieved a significantly higher (P = 0.003) reduction of the proteolytic activity in L.
However, the substrate is not specific for LAL, and the method involves 2 assays performed in parallel, 1 in the presence of an LAL-specific covalent inactivator Lalistat-2 (5).
Optilite assays currently include: Freelite[R] serum free light chain assays, IgG subclasses (lgG1-lgG4), IgG, Low Level IgG (CSF/urine) IgA, IgA Subclasses (lgA1-lgA2), IgM, IgD,' Acid Glycoprotein, Albumin, Low Level Albumin (CSF/urine), Antistreptolysin O, Beta-2Microglobulin, Ceruloplasmin, CH50, Cystatin C, C3c, C4, CI inactivator, Haptoglobin, Hevylite IgA Kappa, Hevylite IgA Lambda, Hevylite IgM Kappa, Hevylite IgM Lambda, Apo A1, Alpha-2-Macroglobulin, Prealbumin, Transferrin
On the other hand, a diet-induced obesity mouse model enabled the demonstration of endothelial p53 as an important inactivator of endothelial nitric oxide synthase (eNOS) [187].
This protein is also considered an HIV protein inactivator because it was proved to inactivate free HIV virions.
The company added that the US Patent Application Serial Number 13/581,187 is generally directed to methods reducing visual field defects and intramyelinic edema resulting from the use of a GABA-aminotransferase inhibitor by using CPP-115, a new and novel GABA-AT inactivator, to treat neurological or psychological disorders.
The loading dose [100 ml which contains 140 mg or 1 million kallikrein inactivator units (KIU)] was given slowly over 20-30 minutes, after induction of anesthesia but prior to sternotomy.
3-Nitropropionate, the toxic substance of Indigofera, is a suicide inactivator of succinate dehydrogenase.
Binary etyhleneimine as an inactivator of foot and mouth disease virus.
This, in turn, may help elucidate the structure of the chemical(s), as well as provide a source of a potentially novel inactivator of nNOS.
The results indicate that the second-generation steroidal inactivator formestane binds tightly to aromatase but not as tightly as a natural substrate (androstenedione).